Stockscreener 앱 받기
1.43
0.00%
0.00
시간 외 거래:
1.43
전일 마감가:
$1.43
열려 있는:
$1.45
하루 거래량:
56,883
Relative Volume:
0.03
시가총액:
$15.09M
수익:
$23.28M
순이익/손실:
$-23.75M
주가수익비율:
-0.4689
EPS:
-3.05
순현금흐름:
$-25.22M
1주 성능:
+0.70%
1개월 성능:
-16.86%
6개월 성능:
-40.91%
1년 성능:
-70.76%
1일 변동 폭
$1.37
$1.474
1주일 범위
$1.365
$1.474
52주 변동 폭
$1.22
$5.28
Lifeward Ltd Stock (LFWD) Company Profile
명칭
Lifeward Ltd
전화
15082511154
주소
200 DONALD LYNCH BLVD., MARLBOROUGH
LFWD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
1.43 | 15.09M | 23.28M | -23.75M | -25.22M | -3.05 |
|
ABT
Abbott Laboratories
|
131.73 | 218.91B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.05 | 139.37B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
348.12 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
83.37 | 106.90B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.60 | 41.45B | 5.72B | 4.17B | 259.90M | 6.97 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-10 | 개시 | Laidlaw | Buy |
| 2017-04-03 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2016-12-16 | 개시 | Oppenheimer | Outperform |
| 2016-07-15 | 개시 | Piper Jaffray | Overweight |
| 2015-05-22 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | 재확인 | Barclays | Equal Weight |
| 2014-10-07 | 개시 | Barclays | Equal Weight |
모두보기
Lifeward Ltd 주식(LFWD)의 최신 뉴스
Lifeward launches sales of ReWalk 7 personal exoskeleton in U.S. - MSN
LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 - MSN
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients By Investing.com - Investing.com South Africa
Lifeward (LFWD) Launches ReWalk 7 Exoskeleton in the U.S., Shares Rise - GuruFocus
Lifeward (LFWD) Launches Next-Gen ReWalk 7 Personal Exoskeleton Nationwide | LFWD Stock News - GuruFocus
Lifeward launches ReWalk 7 exoskeleton for spinal injury patients - Investing.com Australia
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market | LFWD Stock News - GuruFocus
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market - GlobeNewswire
Lifeward Launches Sales Of The ReWalk 7 Personal Exoskeleton In U.S. Market - Barchart.com
Lifeward Ltd. reports preliminary Q1 financial results - Investing.com Australia
Lifeward Ltd. reports preliminary Q1 financial results By Investing.com - Investing.com Canada
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges - Investing.com Australia
ReWalk Robotics stock hits 52-week low at $1.25 amid market challenges By Investing.com - Investing.com South Africa
Lifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton - TradingView
Lifeward gains FDA clearance for new ReWalk exoskeleton - Investing.com
Sector Update: Health Care Stocks Softer Thursday Afternoon -March 13, 2025 at 02:06 pm EDT - Marketscreener.com
Sector Update: Health Care -March 13, 2025 at 01:43 pm EDT - Marketscreener.com
What's Going On With Lifeward Shares Thursday?Lifeward (NASDAQ:LFWD) - Benzinga
FDA Approval of ReWalk7 Sends Lifeward (LFWD) Stock Climbing - Stocks Telegraph
Lifeward announces FDA clearance for ReWalk 7 exoskeleton - TipRanks
Lifeward Receives FDA Clearance for ReWalk 7 Exoskeleton; Shares Jump -March 13, 2025 at 09:41 am EDT - Marketscreener.com
Lifeward gains FDA clearance for new ReWalk exoskeleton By Investing.com - Investing.com UK
FDA Issues Clearance for ReWalk 7 Exoskeleton - GlobeNewswire
Revolutionary ReWalk 7 Exoskeleton Gets FDA Green Light, Medicare Coverage Ready - StockTitan
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright - Investing.com Australia
Positive Outlook for Lifeward Driven by Strategic Partnerships and Market Expansion Initiatives - TipRanks
Lifeward stock holds Buy rating and $13 target from H.C. Wainwright By Investing.com - Investing.com South Africa
Lifeward reports operating loss of USD 15.2M in Q4 2024 - Medical Buyer
Rewalk Robotics Earnings Call: Growth Amid Challenges - TipRanks
Lifeward Ltd (LFWD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
Lifeward Ltd. Reports Strong 2024 Revenue Growth - TipRanks
Lifeward: Q4 Earnings Snapshot - The Washington Post
Lifeward earnings missed by $0.19, revenue fell short of estimates - Investing.com South Africa
Lifeward Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Lifeward (LFWD) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Lifeward Ltd Reports Q4 2024 Earnings: EPS of -$1.73 Misses Esti - GuruFocus.com
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results - TradingView
Lifeward reports Q4 EPS ($1.73) vs (66c) last year - TipRanks
Lifeward Ltd. Reports Record Annual Revenue of $25.7 Million and Launches 2025 Sustainable Growth Plan - Nasdaq
Lifeward expects Q1 revenue to be the lowest of the year - TipRanks
Lifeward Ltd (LFWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.32%
자본화:
|
볼륨(24시간):